Notice2023-07992
Solicitation of Nominations for Appointment to the Advisory Council for the Elimination of Tuberculosis
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 17, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), is seeking nominations for membership on the Advisory Council for the Elimination of Tuberculosis (ACET). ACET consists of 10 experts including the Chair in fields associated with public health, epidemiology, immunology, infectious diseases, pulmonary disease, pediatrics, tuberculosis, microbiology, and preventive health care delivery.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 73 (Monday, April 17, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 73 (Monday, April 17, 2023)]
[Notices]
[Page 23427]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-07992]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Council for the Elimination of Tuberculosis
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), within
the Department of Health and Human Services (HHS), is seeking
nominations for membership on the Advisory Council for the Elimination
of Tuberculosis (ACET). ACET consists of 10 experts including the Chair
in fields associated with public health, epidemiology, immunology,
infectious diseases, pulmonary disease, pediatrics, tuberculosis,
microbiology, and preventive health care delivery.
DATES: Nominations for membership on ACET must be received no later
than August 31, 2023. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to <a href="/cdn-cgi/l/email-protection#90fef3f8f8e3e4e0e0fffcf9f3e9d0f3f4f3bef7ffe6"><span class="__cf_email__" data-cfemail="bdd3ded5d5cec9cdcdd2d1d4dec4fdded9de93dad2cb">[email protected]</span></a>
with the subject line ``ACET 2024 Nomination'' or faxed to (404) 639-
8600.
FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management
Lead, Office of Policy, Planning, and Partnerships, National Center for
HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6, Atlanta,
Georgia 30329-4027. Telephone: (404) 639-3423; Email: <a href="/cdn-cgi/l/email-protection#86cbc5e9e8e2eff2c6e5e2e5a8e1e9f0"><span class="__cf_email__" data-cfemail="5b161834353f322f1b383f38753c342d">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Advisory Council for the Elimination of
Tuberculosis (ACET) provides advice and recommendations regarding the
elimination of tuberculosis (TB) to the Secretary, Department of Health
and Human Services (HHS); the Assistant Secretary for Health, HHS; and
the Director, Centers for Disease Control and Prevention (CDC). ACET
(a) makes recommendations on policies, strategies, objectives, and
priorities; (b) addresses development and application of new
technologies; (c) provides guidance and review of CDC's TB prevention
research portfolio and program priorities; and (d) reviews the extent
to which progress has been made toward eliminating TB.
Nominations are sought for persons who have expertise and
qualifications necessary to contribute to the accomplishment of the
objectives of ACET. Nominees will be selected on the basis of their
expertise in public health, epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics, tuberculosis, microbiology, or
preventive health care delivery. Federal employees will not be
considered for membership. Members may be invited to serve for up to
four-year terms. Selection of members is based on candidates'
qualifications to contribute to the accomplishment of ACET objectives.
HHS policy stipulates that committee membership be balanced in
terms of points of view represented and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens and cannot be full-time employees of the
U.S. Government. Current participation on federal workgroups or prior
experience serving on a federal advisory committee does not disqualify
a candidate; however, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships.
Committee members are Special Government Employees, requiring the
filing of financial disclosure reports at the beginning of and annually
during their terms. CDC reviews potential candidates for ACET
membership each year and provides a slate of nominees for consideration
to the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment near the start of the term in July
2024, or as soon as the HHS selection process is completed. Note that
the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year. Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, and email address).
[ssquf] At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (i.e., CDC, National Institutes of
Health, Food and Drug Administration, etc.).
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-07992 Filed 4-14-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 17, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.